ArticleCirculation. Cardiovascular quality and outcomes2022
Relationship Between Social Determinants of Health and Antihypertensive Medication Adherence in a Medicaid Cohort.
Article in Circulation. Cardiovascular quality and outcomes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 24 citations in OpenAlex.
- Association Between Social Determinants of Health and Adherence to Antihypertensive Medications in US Patients With Uncontrolled, Treated Hypertension.Circulation. Population health and outcomes · 2026Trial
- Real-World Adherence Patterns and Predictors of GLP-1 Receptor Agonist Use for Obesity Management in a Medicaid Population.Advances in therapy · 2026Article
- From pantry to physiology: A narrative review linking food insecurity to biological dysfunction.Dialogues in health · 2026Review
- Hypertension in Women Across the Life Cycle: Unique Aspects and Challenges.Current hypertension reports · 2026Review
- Psychosocial Support as a Multidisciplinary Asset in Hypertension Care: A Systematic Review of Medication Adherence, Blood Pressure Outcomes, and Social Context Exposures.Journal of multidisciplinary healthcare · 2026Review
- Observational
- A Narrative Review on Nitrate-Rich Diets as Adjuncts to Antihypertensive Therapy: Enhancing Treatment Efficacy via Oxidative Stress Modulation.Biomedicines · 2025Review
- Assessing hypertension knowledge and its association with sociodemographic variables among hypertensive patients in Bangladesh.Scientific reports · 2025Article
- Social Determinants of Health and Medication Adherence in Older Adults with Prevalent Chronic Conditions in the United States: An Analysis of the National Health and Nutrition Examination Survey (NHANES) 2009-2018.Pharmacy (Basel, Switzerland) · 2025Article
- Prognosis of apparent treatment-resistant hypertension and poor adherence: a nationwide cohort study.Hypertension research : official journal of the Japanese Society of Hypertension · 2025Observational
- Model-based estimation of individual-level social determinants of health and its applications in All of Us.Journal of the American Medical Informatics Association : JAMIA · 2024Article
- Potential benefits of incorporating social determinants of health screening on comprehensive medication management effectiveness.Journal of managed care & specialty pharmacy · 2024Article
- Combining zip code-based population data and pharmacy administrative claims data to create measures of social determinants of health.Journal of managed care & specialty pharmacy · 2024Article
- Development and efficacy of mobile application to improve medication adherence for persons with cardiac disease.ARYA atherosclerosis · 2024Article
- Exploratory analysis of medication adherence and social determinants of health among older adults with diabetes.Exploratory research in clinical and social pharmacy · 2023Article
- The Impact of Non-Adherence to Antihypertensive Drug Therapy.Healthcare (Basel, Switzerland) · 2023Article
- Antihypertensive and Lipid-Lowering Medication Adherence in Young Adults With Youth-Onset Type 2 Diabetes.JAMA network open · 2023Observational
- Financial hardship and major adverse cardiovascular events: The role of advanced cardiac imaging.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023Article
- Social Determinants of Health Influence Future Health Care Costs in the Medicaid Cohort of the District of Columbia Study.The Milbank quarterly · 2022Article
- Social Determinants of Cardiovascular Health in an Era of Rising Social Disadvantage.Circulation. Cardiovascular quality and outcomes · 2022Article
Corrections and comments
- Commented on by
Authors and funding
7 authors at 4 institutions in 1 country.
Funding
Abstract
backgroundLittle is known about the relationship between social determinants of health (SDH) and medication adherence among Medicaid beneficiaries with hypertension.
methodsWe conducted a posthoc subgroup analysis of 3044 adult Medicaid beneficiaries who enrolled in a parent prospective cohort study and had a diagnosis of hypertension based on their Medicaid claims during a 24-month period before study enrollment. We calculated the proportion of days covered by at least one antihypertensive medication during the first 12 months after study enrollment using the prescription claims data. We measured numerous SDH at the time of study enrollment and we categorized our hypertension cohort into 4 social risk groups based on their response profiles to the SDH variables. We compared the mean proportion of days covered by the different levels of the SDH factors. We modeled the odds of being covered by an antihypertensive medication daily throughout the follow-up period by social risk group, adjusted for age, sex, and disease severity using a generalized linear model.
resultsThe nonrandom sample was predominately Black (93%), female (62%) and had completed high school (77%). The mean proportion of days covered varied significantly by different SDH, such as food insecurity (49%-56%), length of time living at present place (47%-57%), smoking status (50%-56%), etc. Social risk group was a significant predictor of medication adherence. Participants in the 2 groups with the most social risks were 36% (adjusted odds ratio=0.64 [95% CI, 0.53-0.78]) and 20% (adjusted odds ratio=0.80 [95% CI, 0.70-0.93]) less adherent to their hypertension therapy compared with participants in the group with the fewest social risks.
conclusionsSocial risks are associated with lower antihypertensive medication adherence in the Medicaid population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.